Exact Mass: 273.1854

Exact Mass Matches: 273.1854

Found 44 metabolites which its exact mass value is equals to given mass value 273.1854, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Valylarginine

(2S)-2-[(2S)-2-amino-3-methylbutanamido]-5-carbamimidamidopentanoic acid

C11H23N5O3 (273.1801)


Valylarginine is a dipeptide composed of valine and arginine. It is an incomplete breakdown product of protein digestion or protein catabolism. Dipeptides are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Some dipeptides are known to have physiological or cell-signalling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

   

Arginylvaline

(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-methylbutanoic acid

C11H23N5O3 (273.1801)


Arginylvaline is a dipeptide composed of arginine and valine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

   

Heptanoylcarnitine

3-(heptanoyloxy)-4-(trimethylazaniumyl)butanoate

C14H27NO4 (273.194)


Heptanoylcarnitine is an acylcarnitine. More specifically, it is an heptanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy.  This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. Heptanoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine heptanoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews]. A human metabolite taken as a putative food compound of mammalian origin [HMDB]

   

4-Methylhexanoylcarnitine

3-[(4-methylhexanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C14H27NO4 (273.194)


4-Methylhexanoylcarnitine is an acylcarnitine. More specifically, it is an 4-methylhexanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 4-Methylhexanoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 4-Methylhexanoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

5-Methylhexanoylcarnitine

3-[(5-methylhexanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C14H27NO4 (273.194)


5-Methylhexanoylcarnitine is an acylcarnitine. More specifically, it is an 5-methylhexanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 5-Methylhexanoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 5-Methylhexanoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

3-Methylhexanoylcarnitine

3-[(3-methylhexanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C14H27NO4 (273.194)


3-Methylhexanoylcarnitine is an acylcarnitine. More specifically, it is an 3-methylhexanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 3-Methylhexanoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 3-Methylhexanoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

Valyl-Arginine

2-[(2-amino-1-hydroxy-3-methylbutylidene)amino]-5-carbamimidamidopentanoic acid

C11H23N5O3 (273.1801)


   
   
   

Arg-val

2-(2-amino-3-methylbutanamido)-5-carbamimidamidopentanoic acid

C11H23N5O3 (273.1801)


A dipeptide formed from L-arginine and L-valine residues.

   

Val-arg

2-(2-amino-5-carbamimidamidopentanamido)-3-methylbutanoic acid

C11H23N5O3 (273.1801)


A dipeptide formed from L-valine and L-asparagine residues.

   

CAR 7:0

3-(heptanoyloxy)-4-(trimethylazaniumyl)butanoate

C14H27NO4 (273.194)


   

(2S)-2,3,3-trideuterio-2-[(2-methylpropan-2-yl)oxycarbonylamino]-3-(2,3,4,5,6-pentadeuteriophenyl)propanoic acid

(2S)-2,3,3-trideuterio-2-[(2-methylpropan-2-yl)oxycarbonylamino]-3-(2,3,4,5,6-pentadeuteriophenyl)propanoic acid

C14H11D8NO4 (273.1816)


   

1-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)pyrrolidine

1-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)pyrrolidine

C16H24BNO2 (273.19)


   

9-((tert-Butoxycarbonyl)amino)nonanoic acid

9-((tert-Butoxycarbonyl)amino)nonanoic acid

C14H27NO4 (273.194)


   

N-(2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)cyclopropanamine

N-(2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)cyclopropanamine

C16H24BNO2 (273.19)


   

(R)-TERT-BUTYL 4-(4-HYDROXYBUTYL)-2,2-DIMETHYLOXAZOLIDINE-3-CARBOXYLATE

(R)-TERT-BUTYL 4-(4-HYDROXYBUTYL)-2,2-DIMETHYLOXAZOLIDINE-3-CARBOXYLATE

C14H27NO4 (273.194)


   

1-(3-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL)PYRROLIDINE

1-(3-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL)PYRROLIDINE

C16H24BNO2 (273.19)


   

N-BIS(TERT-BUTYLPROPIONATE)AMINE

N-BIS(TERT-BUTYLPROPIONATE)AMINE

C14H27NO4 (273.194)


   

1-(Triisopropylsilyl)-1H-indole

1-(Triisopropylsilyl)-1H-indole

C17H27NSi (273.1913)


   

tert-butyl 4,4-bis(2-hydroxyethyl)piperidine-1-carboxylate

tert-butyl 4,4-bis(2-hydroxyethyl)piperidine-1-carboxylate

C14H27NO4 (273.194)


   

(4R,6R)-tert-Butyl-6-(2-aminoethyl)-2,2-dimethyl-1,3-dioxane-4-acetate

(4R,6R)-tert-Butyl-6-(2-aminoethyl)-2,2-dimethyl-1,3-dioxane-4-acetate

C14H27NO4 (273.194)


   

2-Fluoro-4-(trans-4-pentylcyclohexyl)-benzonitrile

2-Fluoro-4-(trans-4-pentylcyclohexyl)-benzonitrile

C18H24FN (273.1893)


   

4-Ethylphenyl 4-trans-propylcyclohexylcarboxylate

4-Ethylphenyl 4-trans-propylcyclohexylcarboxylate

C18H25O2- (273.1854)


   

(4S,trans)-1,1-Dimethylethyl-6-aminoethyl-2,2-dimethyl-1,3-dioxane-4-acetate

(4S,trans)-1,1-Dimethylethyl-6-aminoethyl-2,2-dimethyl-1,3-dioxane-4-acetate

C14H27NO4 (273.194)


   

1-[3-(4-p-tolyl-piperazin-1-yl)-azetidin-1-yl]-ethanone

1-[3-(4-p-tolyl-piperazin-1-yl)-azetidin-1-yl]-ethanone

C16H23N3O (273.1841)


   

1-(1-benzylpiperidin-4-yl)-1,3-diazinan-2-one

1-(1-benzylpiperidin-4-yl)-1,3-diazinan-2-one

C16H23N3O (273.1841)


   

7,7-azanediyldiheptanoic acid

7,7-azanediyldiheptanoic acid

C14H27NO4 (273.194)


   

2-methyl-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,2,3,4-tetrahydroisoquinoline

2-methyl-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,2,3,4-tetrahydroisoquinoline

C16H24BNO2 (273.19)


   

2-METHYL-6-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1,2,3,4-TETRAHYDROISOQUINOLINE

2-METHYL-6-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1,2,3,4-TETRAHYDROISOQUINOLINE

C16H24BNO2 (273.19)


   

1-(2-Ethoxy-ethyl)-2-piperidin-4-yl-1H-benzimidazole

1-(2-Ethoxy-ethyl)-2-piperidin-4-yl-1H-benzimidazole

C16H23N3O (273.1841)


   

s-Triazine, 1,2-dihydro-1-(p-butylphenyl)-4,6-diamino-2,2-dimethyl-

s-Triazine, 1,2-dihydro-1-(p-butylphenyl)-4,6-diamino-2,2-dimethyl-

C15H23N5 (273.1953)


   

1-Butyl-3-(2-hydroxyethylamino)-5,6,7,8-tetrahydroisoquinoline-4-carbonitrile

1-Butyl-3-(2-hydroxyethylamino)-5,6,7,8-tetrahydroisoquinoline-4-carbonitrile

C16H23N3O (273.1841)


   

(9Z,12Z,15Z)-octadecatrien-6-ynoate

(9Z,12Z,15Z)-octadecatrien-6-ynoate

C18H25O2- (273.1854)


   

(2S,3S,7R)-2,3-diamino-8-(2-amino-4,5-dihydro-1H-imidazol-5-yl)-7-hydroxyoctanoic acid

(2S,3S,7R)-2,3-diamino-8-(2-amino-4,5-dihydro-1H-imidazol-5-yl)-7-hydroxyoctanoic acid

C11H23N5O3 (273.1801)


   

4-Methylhexanoylcarnitine

4-Methylhexanoylcarnitine

C14H27NO4 (273.194)


   

5-Methylhexanoylcarnitine

5-Methylhexanoylcarnitine

C14H27NO4 (273.194)


   

3-Methylhexanoylcarnitine

3-Methylhexanoylcarnitine

C14H27NO4 (273.194)


   

N-Decanoyl-L-Homoserine

N-Decanoyl-L-Homoserine

C14H27NO4 (273.194)


   

N-dodecanoyl-(2S)-hydroxyglycine

N-dodecanoyl-(2S)-hydroxyglycine

C14H27NO4 (273.194)


   

O-heptanoylcarnitine

O-heptanoylcarnitine

C14H27NO4 (273.194)


An O-acylcarnitine that is the O-heptanoyl derivative of carnitine.

   
   

NA-Ser 11:0

NA-Ser 11:0

C14H27NO4 (273.194)


   

NA-Thr 10:0

NA-Thr 10:0

C14H27NO4 (273.194)